Skip to main content
. 2011 Aug 27;378(9793):771–784. doi: 10.1016/S0140-6736(11)60993-8

Figure 2.

Figure 2

Relevance of quantitative ER and PR measurement (fmol/mg cytosol protein) to the tamoxifen versus control recurrence rate ratio

Outcome by allocated treatment in trials of about 5 years of adjuvant tamoxifen. Other ER poor includes ER-negative by immunohistochemistry and ER unspecified, but less than 10 fmol/mg. ER=oestrogen receptor. PR=progesterone receptor. O–E=observed minus expected.